Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
20.76
+0.18 (0.87%)
At close: Mar 6, 2026, 4:00 PM EST
21.07
+0.31 (1.49%)
After-hours: Mar 6, 2026, 7:44 PM EST
Alto Neuroscience Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Alto Neuroscience stock have an average target of 23, with a low estimate of 4.00 and a high estimate of 50. The average target predicts an increase of 10.79% from the current stock price of 20.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Alto Neuroscience stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $27 → $28 | Strong Buy | Maintains | $27 → $28 | +34.87% | Feb 17, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $30 | Strong Buy | Maintains | $15 → $30 | +44.51% | Jan 5, 2026 |
| BTIG | BTIG | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +30.06% | Nov 17, 2025 |
| Baird | Baird | Buy Maintains $16 → $22 | Buy | Maintains | $16 → $22 | +5.97% | Nov 13, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +20.42% | Nov 12, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.29
from -2.50
EPS Next Year
-2.35
from -2.29
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.26 | -1.78 | ||||
| Avg | -2.29 | -2.35 | ||||
| Low | -2.33 | -3.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.